Healthcare Finance News November 11, 2024
Jeff Lagasse

The approach includes real-time analytics and specialty spend management capabilities.

Independent pharmacy benefit manager CerpassRx is looking to better manage specialty drug spend by teaming up with Waltz Health on an artificial intelligence-powered platform called Intelligent Specialty Engine.

The idea is that the approach, which includes real-time analytics and specialty spend management capabilities, will improve transparency and smooth the specialty drug experience for health plans and employers.

Data from the Assistant Secretary for Planning and Evaluation published in 2022 showed specialty drugs account for more than half of total drug spend. Health plans and self-insured employers are facing increasing pressure to manage these expenses more effectively, and in some cases are turning to PBMs.

WHAT’S THE IMPACT?

According to CarepassRx,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Pharma, Pharma / Biotech, Technology
Related Articles:
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens

Share This Article